Diagnostic Specialty Enzymes

Diagnostic Specialty Enzymes

Global Diagnostic Specialty Enzymes Market to Reach US$1.7 Billion by 2030

The global market for Diagnostic Specialty Enzymes estimated at US$1.1 Billion in the year 2023, is expected to reach US$1.7 Billion by 2030, growing at a CAGR of 6.2% over the analysis period 2023-2030. Polymerases & Nucleases, one of the segments analyzed in the report, is expected to record a 7.0% CAGR and reach US$726.2 Million by the end of the analysis period. Growth in the Proteases segment is estimated at 6.5% CAGR over the analysis period.

The U.S. Market is Estimated at US$305.1 Million While China is Forecast to Grow at 5.7% CAGR

The Diagnostic Specialty Enzymes market in the U.S. is estimated at US$305.1 Million in the year 2023. China, the world`s second largest economy, is forecast to reach a projected market size of US$266.7 Million by the year 2030 trailing a CAGR of 5.7% over the analysis period 2023-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 5.5% and 5.2% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 4.6% CAGR.

Global Diagnostic Specialty Enzymes Market - Key Trends & Drivers Summarized

Why Are Diagnostic Specialty Enzymes Essential in Modern Diagnostics?

Diagnostic specialty enzymes are crucial components in the development of diagnostic assays, playing a fundamental role in the detection of various diseases and conditions. These enzymes are used in clinical chemistry, molecular diagnostics, and immunoassays to catalyze specific reactions that help identify biomarkers for diseases such as diabetes, cardiovascular conditions, and infectious diseases. The precision and efficiency of specialty enzymes make them indispensable in diagnostics, enabling healthcare professionals to deliver accurate and timely results. As the demand for point-of-care testing (POCT) and home diagnostic kits grows, the use of specialty enzymes is expanding, providing the essential biochemical tools needed to meet the rising need for quick and accurate testing solutions.

How Are Technological Advancements Influencing the Diagnostic Enzymes Market?

The diagnostic specialty enzymes market is witnessing significant growth due to technological advancements in enzyme engineering and production methods. Genetic engineering and recombinant DNA technology are enhancing the stability, specificity, and activity of these enzymes, making them more effective in diagnostic applications. Additionally, innovations in microfluidics and lab-on-a-chip technologies are integrating enzymes into compact diagnostic devices, enabling faster and more accurate testing in clinical and point-of-care settings. The development of enzyme-linked immunosorbent assays (ELISAs) and other enzyme-based diagnostic platforms is also evolving, allowing for high-throughput and multiplex testing that can simultaneously detect multiple biomarkers. These advancements are increasing the efficiency and versatility of diagnostic specialty enzymes, broadening their application in modern diagnostics.

How Are Market Demands and Healthcare Trends Shaping the Enzymes Market?

The rising demand for early diagnosis and preventive healthcare is significantly influencing the diagnostic specialty enzymes market. As healthcare systems worldwide shift towards preventive care, there is a growing emphasis on the development of diagnostic tools that can detect diseases at early stages. Enzymes play a critical role in the creation of these tools, particularly in the detection of metabolic disorders, infections, and genetic conditions. The increasing incidence of chronic diseases like diabetes and cardiovascular conditions is driving demand for enzyme-based diagnostic tests that offer quick and reliable results. Additionally, the growth of home-based testing and self-monitoring devices, such as glucose monitors and rapid antigen tests, is expanding the use of diagnostic specialty enzymes beyond traditional laboratory settings. The trend towards personalized medicine and tailored treatments is also influencing the market, as these enzymes facilitate precise and targeted diagnostic assays that support individualized healthcare.

What Factors Are Driving Growth in the Diagnostic Specialty Enzymes Market?

The growth in the diagnostic specialty enzymes market is driven by several factors, including technological advancements in enzyme engineering, the rising prevalence of chronic and infectious diseases, and the increasing demand for rapid diagnostic testing solutions. The shift towards preventive and personalized healthcare is encouraging the development of enzyme-based diagnostic tools that provide quick, accurate, and portable solutions. The expansion of point-of-care testing (POCT) and home-based diagnostic kits, particularly in the wake of the COVID-19 pandemic, is further driving demand for specialty enzymes that are tailored for these applications. Additionally, the growing emphasis on developing sensitive and specific diagnostic assays for diseases like cancer, diabetes, and cardiovascular conditions is propelling investment in enzyme technology. The push for accessible healthcare solutions in emerging markets, supported by government initiatives and healthcare reforms, is also contributing to the expansion of the diagnostic specialty enzymes market globally.

Select Competitors (Total 14 Featured) -
  • Advanced Enzymes Technologies Ltd.
  • Affymetrix, Inc.
  • Amano Enzymes Inc.
  • American Laboratories, Inc.
  • Amicogen, Inc.
  • BASF
  • BBI Solutions
  • Biocatalysts Ltd.
  • Codexis, Inc.
  • Dyadic International
  • F. Hoffmann-La Roche Ltd.
  • Life technologies
  • Micogen, Inc.
  • Nagase & Co. Ltd.
  • Novozymes A/S
  • Roche Holding Ag
  • Thermo Fisher Scientific, Inc.
Please note: Reports are sold as single-site single-user licenses. Electronic versions require 24-48 hours as each copy is customized to the client with digital controls and custom watermarks. The Publisher uses digital controls protecting against copying and printing is restricted to one full copy to be used at the same location.

The latest version of Adobe Acrobat Reader is required to view the report. Upon ordering an electronic version, the Publisher will provide a link to download the purchased report.

Prior to fulfillment of an order, the client will be required to sign a document detailing the purchase terms for a publication from this publisher.


I. METHODOLOGY
II. EXECUTIVE SUMMARY
1. MARKET OVERVIEW
Influencer Market Insights
World Market Trajectories
Impact of Covid-19 and a Looming Global Recession
Diagnostic Specialty Enzymes – Global Key Competitors Percentage Market Share in 2024 (E)
Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2024 (E)
2. FOCUS ON SELECT PLAYERS
3. MARKET TRENDS & DRIVERS
Rising Demand for Early Diagnosis and Preventive Healthcare
Growth in Point-of-Care and Rapid Testing Solutions Boosting Enzyme Use
Increasing Adoption of Specialty Enzymes in Molecular Diagnostics
Technological Advancements in Enzyme Engineering for Enhanced Sensitivity
Surge in Use of Enzymes for Cancer and Genetic Disorder Detection
Development of Multiplex Diagnostic Assays Incorporating Specialty Enzymes
Growth in Home-Based and Self-Monitoring Diagnostic Kits
Expansion of Diagnostic Services in Emerging Markets Supporting Enzyme Demand
Rising Focus on Personalized Medicine and Targeted Diagnostics
Increasing Collaboration Between Diagnostic Companies and Enzyme Providers
Growth in Use of Enzymes for Monitoring Infectious Diseases
Advancements in Microfluidics and Lab-on-a-Chip Technologies Using Enzymes
Rising Investment in R&D for Enzyme Optimization and Stability
Expansion of Enzyme Applications in Veterinary Diagnostics
4. GLOBAL MARKET PERSPECTIVE
TABLE 1: World Diagnostic Specialty Enzymes Market Analysis of Annual Sales in US$ Thousand for Years 2014 through 2030
TABLE 2: World Recent Past, Current & Future Analysis for Diagnostic Specialty Enzymes by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
TABLE 3: World Historic Review for Diagnostic Specialty Enzymes by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 4: World 16-Year Perspective for Diagnostic Specialty Enzymes by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2014, 2024 & 2030
TABLE 5: World Recent Past, Current & Future Analysis for Polymerases & Nucleases by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
TABLE 6: World Historic Review for Polymerases & Nucleases by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 7: World 16-Year Perspective for Polymerases & Nucleases by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
TABLE 8: World Recent Past, Current & Future Analysis for Proteases by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
TABLE 9: World Historic Review for Proteases by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 10: World 16-Year Perspective for Proteases by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
TABLE 11: World Recent Past, Current & Future Analysis for Carbohydrates by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
TABLE 12: World Historic Review for Carbohydrates by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 13: World 16-Year Perspective for Carbohydrates by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
TABLE 14: World Recent Past, Current & Future Analysis for Oxidases by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
TABLE 15: World Historic Review for Oxidases by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 16: World 16-Year Perspective for Oxidases by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
TABLE 17: World Recent Past, Current & Future Analysis for Other Products by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
TABLE 18: World Historic Review for Other Products by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 19: World 16-Year Perspective for Other Products by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
TABLE 20: World Recent Past, Current & Future Analysis for Clinical Chemistry by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
TABLE 21: World Historic Review for Clinical Chemistry by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 22: World 16-Year Perspective for Clinical Chemistry by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
TABLE 23: World Recent Past, Current & Future Analysis for Molecular Diagnostics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
TABLE 24: World Historic Review for Molecular Diagnostics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 25: World 16-Year Perspective for Molecular Diagnostics by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
TABLE 26: World Recent Past, Current & Future Analysis for Immunoassays by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
TABLE 27: World Historic Review for Immunoassays by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 28: World 16-Year Perspective for Immunoassays by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
TABLE 29: World Recent Past, Current & Future Analysis for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
TABLE 30: World Historic Review for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 31: World 16-Year Perspective for Other Applications by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
III. MARKET ANALYSIS
UNITED STATES
Diagnostic Specialty Enzymes Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2024 (E)
TABLE 32: USA Recent Past, Current & Future Analysis for Diagnostic Specialty Enzymes by Product - Polymerases & Nucleases, Proteases, Carbohydrates, Oxidases and Other Products - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 33: USA Historic Review for Diagnostic Specialty Enzymes by Product - Polymerases & Nucleases, Proteases, Carbohydrates, Oxidases and Other Products Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 34: USA 16-Year Perspective for Diagnostic Specialty Enzymes by Product - Percentage Breakdown of Value Sales for Polymerases & Nucleases, Proteases, Carbohydrates, Oxidases and Other Products for the Years 2014, 2024 & 2030
TABLE 35: USA Recent Past, Current & Future Analysis for Diagnostic Specialty Enzymes by Application - Clinical Chemistry, Molecular Diagnostics, Immunoassays and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 36: USA Historic Review for Diagnostic Specialty Enzymes by Application - Clinical Chemistry, Molecular Diagnostics, Immunoassays and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 37: USA 16-Year Perspective for Diagnostic Specialty Enzymes by Application - Percentage Breakdown of Value Sales for Clinical Chemistry, Molecular Diagnostics, Immunoassays and Other Applications for the Years 2014, 2024 & 2030
CANADA
TABLE 38: Canada Recent Past, Current & Future Analysis for Diagnostic Specialty Enzymes by Product - Polymerases & Nucleases, Proteases, Carbohydrates, Oxidases and Other Products - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 39: Canada Historic Review for Diagnostic Specialty Enzymes by Product - Polymerases & Nucleases, Proteases, Carbohydrates, Oxidases and Other Products Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 40: Canada 16-Year Perspective for Diagnostic Specialty Enzymes by Product - Percentage Breakdown of Value Sales for Polymerases & Nucleases, Proteases, Carbohydrates, Oxidases and Other Products for the Years 2014, 2024 & 2030
TABLE 41: Canada Recent Past, Current & Future Analysis for Diagnostic Specialty Enzymes by Application - Clinical Chemistry, Molecular Diagnostics, Immunoassays and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 42: Canada Historic Review for Diagnostic Specialty Enzymes by Application - Clinical Chemistry, Molecular Diagnostics, Immunoassays and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 43: Canada 16-Year Perspective for Diagnostic Specialty Enzymes by Application - Percentage Breakdown of Value Sales for Clinical Chemistry, Molecular Diagnostics, Immunoassays and Other Applications for the Years 2014, 2024 & 2030
JAPAN
Diagnostic Specialty Enzymes Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2024 (E)
TABLE 44: Japan Recent Past, Current & Future Analysis for Diagnostic Specialty Enzymes by Product - Polymerases & Nucleases, Proteases, Carbohydrates, Oxidases and Other Products - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 45: Japan Historic Review for Diagnostic Specialty Enzymes by Product - Polymerases & Nucleases, Proteases, Carbohydrates, Oxidases and Other Products Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 46: Japan 16-Year Perspective for Diagnostic Specialty Enzymes by Product - Percentage Breakdown of Value Sales for Polymerases & Nucleases, Proteases, Carbohydrates, Oxidases and Other Products for the Years 2014, 2024 & 2030
TABLE 47: Japan Recent Past, Current & Future Analysis for Diagnostic Specialty Enzymes by Application - Clinical Chemistry, Molecular Diagnostics, Immunoassays and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 48: Japan Historic Review for Diagnostic Specialty Enzymes by Application - Clinical Chemistry, Molecular Diagnostics, Immunoassays and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 49: Japan 16-Year Perspective for Diagnostic Specialty Enzymes by Application - Percentage Breakdown of Value Sales for Clinical Chemistry, Molecular Diagnostics, Immunoassays and Other Applications for the Years 2014, 2024 & 2030
CHINA
Diagnostic Specialty Enzymes Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2024 (E)
TABLE 50: China Recent Past, Current & Future Analysis for Diagnostic Specialty Enzymes by Product - Polymerases & Nucleases, Proteases, Carbohydrates, Oxidases and Other Products - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 51: China Historic Review for Diagnostic Specialty Enzymes by Product - Polymerases & Nucleases, Proteases, Carbohydrates, Oxidases and Other Products Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 52: China 16-Year Perspective for Diagnostic Specialty Enzymes by Product - Percentage Breakdown of Value Sales for Polymerases & Nucleases, Proteases, Carbohydrates, Oxidases and Other Products for the Years 2014, 2024 & 2030
TABLE 53: China Recent Past, Current & Future Analysis for Diagnostic Specialty Enzymes by Application - Clinical Chemistry, Molecular Diagnostics, Immunoassays and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 54: China Historic Review for Diagnostic Specialty Enzymes by Application - Clinical Chemistry, Molecular Diagnostics, Immunoassays and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 55: China 16-Year Perspective for Diagnostic Specialty Enzymes by Application - Percentage Breakdown of Value Sales for Clinical Chemistry, Molecular Diagnostics, Immunoassays and Other Applications for the Years 2014, 2024 & 2030
EUROPE
Diagnostic Specialty Enzymes Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2024 (E)
TABLE 56: Europe Recent Past, Current & Future Analysis for Diagnostic Specialty Enzymes by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
TABLE 57: Europe Historic Review for Diagnostic Specialty Enzymes by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 58: Europe 16-Year Perspective for Diagnostic Specialty Enzymes by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK and Rest of Europe Markets for Years 2014, 2024 & 2030
TABLE 59: Europe Recent Past, Current & Future Analysis for Diagnostic Specialty Enzymes by Product - Polymerases & Nucleases, Proteases, Carbohydrates, Oxidases and Other Products - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 60: Europe Historic Review for Diagnostic Specialty Enzymes by Product - Polymerases & Nucleases, Proteases, Carbohydrates, Oxidases and Other Products Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 61: Europe 16-Year Perspective for Diagnostic Specialty Enzymes by Product - Percentage Breakdown of Value Sales for Polymerases & Nucleases, Proteases, Carbohydrates, Oxidases and Other Products for the Years 2014, 2024 & 2030
TABLE 62: Europe Recent Past, Current & Future Analysis for Diagnostic Specialty Enzymes by Application - Clinical Chemistry, Molecular Diagnostics, Immunoassays and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 63: Europe Historic Review for Diagnostic Specialty Enzymes by Application - Clinical Chemistry, Molecular Diagnostics, Immunoassays and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 64: Europe 16-Year Perspective for Diagnostic Specialty Enzymes by Application - Percentage Breakdown of Value Sales for Clinical Chemistry, Molecular Diagnostics, Immunoassays and Other Applications for the Years 2014, 2024 & 2030
FRANCE
Diagnostic Specialty Enzymes Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2024 (E)
TABLE 65: France Recent Past, Current & Future Analysis for Diagnostic Specialty Enzymes by Product - Polymerases & Nucleases, Proteases, Carbohydrates, Oxidases and Other Products - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 66: France Historic Review for Diagnostic Specialty Enzymes by Product - Polymerases & Nucleases, Proteases, Carbohydrates, Oxidases and Other Products Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 67: France 16-Year Perspective for Diagnostic Specialty Enzymes by Product - Percentage Breakdown of Value Sales for Polymerases & Nucleases, Proteases, Carbohydrates, Oxidases and Other Products for the Years 2014, 2024 & 2030
TABLE 68: France Recent Past, Current & Future Analysis for Diagnostic Specialty Enzymes by Application - Clinical Chemistry, Molecular Diagnostics, Immunoassays and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 69: France Historic Review for Diagnostic Specialty Enzymes by Application - Clinical Chemistry, Molecular Diagnostics, Immunoassays and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 70: France 16-Year Perspective for Diagnostic Specialty Enzymes by Application - Percentage Breakdown of Value Sales for Clinical Chemistry, Molecular Diagnostics, Immunoassays and Other Applications for the Years 2014, 2024 & 2030
GERMANY
Diagnostic Specialty Enzymes Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2024 (E)
TABLE 71: Germany Recent Past, Current & Future Analysis for Diagnostic Specialty Enzymes by Product - Polymerases & Nucleases, Proteases, Carbohydrates, Oxidases and Other Products - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 72: Germany Historic Review for Diagnostic Specialty Enzymes by Product - Polymerases & Nucleases, Proteases, Carbohydrates, Oxidases and Other Products Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 73: Germany 16-Year Perspective for Diagnostic Specialty Enzymes by Product - Percentage Breakdown of Value Sales for Polymerases & Nucleases, Proteases, Carbohydrates, Oxidases and Other Products for the Years 2014, 2024 & 2030
TABLE 74: Germany Recent Past, Current & Future Analysis for Diagnostic Specialty Enzymes by Application - Clinical Chemistry, Molecular Diagnostics, Immunoassays and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 75: Germany Historic Review for Diagnostic Specialty Enzymes by Application - Clinical Chemistry, Molecular Diagnostics, Immunoassays and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 76: Germany 16-Year Perspective for Diagnostic Specialty Enzymes by Application - Percentage Breakdown of Value Sales for Clinical Chemistry, Molecular Diagnostics, Immunoassays and Other Applications for the Years 2014, 2024 & 2030
ITALY
TABLE 77: Italy Recent Past, Current & Future Analysis for Diagnostic Specialty Enzymes by Product - Polymerases & Nucleases, Proteases, Carbohydrates, Oxidases and Other Products - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 78: Italy Historic Review for Diagnostic Specialty Enzymes by Product - Polymerases & Nucleases, Proteases, Carbohydrates, Oxidases and Other Products Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 79: Italy 16-Year Perspective for Diagnostic Specialty Enzymes by Product - Percentage Breakdown of Value Sales for Polymerases & Nucleases, Proteases, Carbohydrates, Oxidases and Other Products for the Years 2014, 2024 & 2030
TABLE 80: Italy Recent Past, Current & Future Analysis for Diagnostic Specialty Enzymes by Application - Clinical Chemistry, Molecular Diagnostics, Immunoassays and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 81: Italy Historic Review for Diagnostic Specialty Enzymes by Application - Clinical Chemistry, Molecular Diagnostics, Immunoassays and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 82: Italy 16-Year Perspective for Diagnostic Specialty Enzymes by Application - Percentage Breakdown of Value Sales for Clinical Chemistry, Molecular Diagnostics, Immunoassays and Other Applications for the Years 2014, 2024 & 2030
UNITED KINGDOM
Diagnostic Specialty Enzymes Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2024 (E)
TABLE 83: UK Recent Past, Current & Future Analysis for Diagnostic Specialty Enzymes by Product - Polymerases & Nucleases, Proteases, Carbohydrates, Oxidases and Other Products - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 84: UK Historic Review for Diagnostic Specialty Enzymes by Product - Polymerases & Nucleases, Proteases, Carbohydrates, Oxidases and Other Products Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 85: UK 16-Year Perspective for Diagnostic Specialty Enzymes by Product - Percentage Breakdown of Value Sales for Polymerases & Nucleases, Proteases, Carbohydrates, Oxidases and Other Products for the Years 2014, 2024 & 2030
TABLE 86: UK Recent Past, Current & Future Analysis for Diagnostic Specialty Enzymes by Application - Clinical Chemistry, Molecular Diagnostics, Immunoassays and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 87: UK Historic Review for Diagnostic Specialty Enzymes by Application - Clinical Chemistry, Molecular Diagnostics, Immunoassays and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 88: UK 16-Year Perspective for Diagnostic Specialty Enzymes by Application - Percentage Breakdown of Value Sales for Clinical Chemistry, Molecular Diagnostics, Immunoassays and Other Applications for the Years 2014, 2024 & 2030
REST OF EUROPE
TABLE 89: Rest of Europe Recent Past, Current & Future Analysis for Diagnostic Specialty Enzymes by Product - Polymerases & Nucleases, Proteases, Carbohydrates, Oxidases and Other Products - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 90: Rest of Europe Historic Review for Diagnostic Specialty Enzymes by Product - Polymerases & Nucleases, Proteases, Carbohydrates, Oxidases and Other Products Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 91: Rest of Europe 16-Year Perspective for Diagnostic Specialty Enzymes by Product - Percentage Breakdown of Value Sales for Polymerases & Nucleases, Proteases, Carbohydrates, Oxidases and Other Products for the Years 2014, 2024 & 2030
TABLE 92: Rest of Europe Recent Past, Current & Future Analysis for Diagnostic Specialty Enzymes by Application - Clinical Chemistry, Molecular Diagnostics, Immunoassays and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 93: Rest of Europe Historic Review for Diagnostic Specialty Enzymes by Application - Clinical Chemistry, Molecular Diagnostics, Immunoassays and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 94: Rest of Europe 16-Year Perspective for Diagnostic Specialty Enzymes by Application - Percentage Breakdown of Value Sales for Clinical Chemistry, Molecular Diagnostics, Immunoassays and Other Applications for the Years 2014, 2024 & 2030
ASIA-PACIFIC
Diagnostic Specialty Enzymes Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2024 (E)
TABLE 95: Asia-Pacific Recent Past, Current & Future Analysis for Diagnostic Specialty Enzymes by Product - Polymerases & Nucleases, Proteases, Carbohydrates, Oxidases and Other Products - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 96: Asia-Pacific Historic Review for Diagnostic Specialty Enzymes by Product - Polymerases & Nucleases, Proteases, Carbohydrates, Oxidases and Other Products Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 97: Asia-Pacific 16-Year Perspective for Diagnostic Specialty Enzymes by Product - Percentage Breakdown of Value Sales for Polymerases & Nucleases, Proteases, Carbohydrates, Oxidases and Other Products for the Years 2014, 2024 & 2030
TABLE 98: Asia-Pacific Recent Past, Current & Future Analysis for Diagnostic Specialty Enzymes by Application - Clinical Chemistry, Molecular Diagnostics, Immunoassays and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 99: Asia-Pacific Historic Review for Diagnostic Specialty Enzymes by Application - Clinical Chemistry, Molecular Diagnostics, Immunoassays and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 100: Asia-Pacific 16-Year Perspective for Diagnostic Specialty Enzymes by Application - Percentage Breakdown of Value Sales for Clinical Chemistry, Molecular Diagnostics, Immunoassays and Other Applications for the Years 2014, 2024 & 2030
REST OF WORLD
TABLE 101: Rest of World Recent Past, Current & Future Analysis for Diagnostic Specialty Enzymes by Product - Polymerases & Nucleases, Proteases, Carbohydrates, Oxidases and Other Products - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 102: Rest of World Historic Review for Diagnostic Specialty Enzymes by Product - Polymerases & Nucleases, Proteases, Carbohydrates, Oxidases and Other Products Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 103: Rest of World 16-Year Perspective for Diagnostic Specialty Enzymes by Product - Percentage Breakdown of Value Sales for Polymerases & Nucleases, Proteases, Carbohydrates, Oxidases and Other Products for the Years 2014, 2024 & 2030
TABLE 104: Rest of World Recent Past, Current & Future Analysis for Diagnostic Specialty Enzymes by Application - Clinical Chemistry, Molecular Diagnostics, Immunoassays and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 105: Rest of World Historic Review for Diagnostic Specialty Enzymes by Application - Clinical Chemistry, Molecular Diagnostics, Immunoassays and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 106: Rest of World 16-Year Perspective for Diagnostic Specialty Enzymes by Application - Percentage Breakdown of Value Sales for Clinical Chemistry, Molecular Diagnostics, Immunoassays and Other Applications for the Years 2014, 2024 & 2030
IV. COMPETITION

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings